CMKLR1 and anthracosis: Last, our exploratory histological analysis of lung specimens suggests that CMKLR1 is a relevant inflammatory biomarker in a wide range of fibrotic lung diseases in addition to IPF, such as sarcoidosis, scleroderma, rheumatoid arthritis, and coal worker pneumoconiosis.